Mirotiv 10 Tablet

Generic Name: Mirogabalin Besylate

Manufacturer: Renata Limited (Bangladesh)

Strength: Each tablet contains Mirogabalin Besylate equivalent to Mirogabalin 10 mg.

Indications:

Mirotiv is indicated for the treatment of neuropathic pain, including:

• Diabetic peripheral neuropathic pain (DPNP)
• Postherpetic neuralgia (PHN)
• Peripheral neuropathic pain (PNP)

Dosage and Administration:

• The usual initial dose for adults is 5 mg twice daily.
• The dose is gradually increased by 5 mg at intervals of at least one week, up to a maximum of 15 mg twice daily, based on individual response and tolerability.
• The dosage may be adjusted between 10 mg and 15 mg twice daily depending on the patient's age and symptoms.
• It can be taken with or without food.

Contraindications:

• Hypersensitivity to mirogabalin.

Side Effects:

The most commonly reported side effects include:

• Somnolence (sleepiness)
• Dizziness
• Peripheral edema (swelling in the extremities)
• Weight gain

Less common side effects may include:

• Blurred vision
• Diplopia (double vision)
• Balance disorder
• Paresthesia (tingling or prickling sensation)
• Dry mouth
• Constipation
• Increased appetite
• Fatigue

Precautions:

• This medicine may cause dizziness, somnolence, or loss of consciousness. Patients should avoid operating dangerous machinery, including driving, until they know how Mirotiv affects them.
• Elderly patients should be monitored carefully due to a potential increased risk of falls and fractures associated with dizziness and somnolence.
• Weight gain has been reported with Mirotiv. Monitor weight and manage appropriately.
• If blurred vision or double vision occurs, consult a doctor.
• Avoid consuming alcohol while taking Mirotiv as it may intensify the impairment of motor skills and the sedating effects of alcohol.
• Use with caution in patients with renal impairment; dosage adjustments are recommended based on creatinine clearance.

Use in Pregnancy and Breastfeeding:

• Pregnancy: Mirotiv should be used during pregnancy only if the potential benefit outweighs the risk to the fetus.
• Breastfeeding: It is not known whether Mirogabalin is excreted in human milk. A decision should be made whether to discontinue nursing or the drug, considering the importance of the drug to the mother.

Storage:

• Store below 30°C in a dry place, away from light and moisture.
• Keep out of reach of children.

Important Note: This information is for general knowledge and informational purposes only, and does not substitute professional medical advice. Always consult your doctor or pharmacist for specific instructions and guidance regarding your medication. They can assess your individual medical condition and provide the most appropriate advice.